[Form 4] Oblong, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Jonathan Schechter, a director of Oblong, Inc. (OBLG), reported on Form 4 that on 09/16/2025 he acquired 10,000 shares of the issuer's common stock at a price of $2.7321 per share and, following the transaction, beneficially owned 10,000 common shares. The filing also discloses outstanding warrants issued earlier that vest beginning six months after grant; those warrants have an exercise price of $3.4144, were dated 10/01/2023, expire on 10/01/2028, and underlying 61,351 shares of common stock held directly.

Positive

• Director purchase of 10,000 common shares on 09/16/2025 at $2.7321, indicating insider acquisition
• Clear disclosure of warrant terms including exercise price $3.4144, grant/exercise timing, and expiration 10/01/2028

Negative

• Outstanding warrants underlying 61,351 shares could be dilutive if exercised
• Form 4 contains no context on transaction purpose or company financials, limiting investor assessment

Insights

Financial Analyst

TL;DR: Director purchased 10,000 shares and holds warrants for 61,351 shares; transaction size is modest relative to typical market-moving insider trades.

The director's open-market acquisition of 10,000 common shares at $2.7321 is a clear insider purchase signal present in the filing. The filing separately documents 61,351 underlying shares from warrants exercisable through 10/01/2028 at $3.4144. For investors assessing immediacy, the reported amounts are explicit and do not provide revenue, earnings, or valuation context in this Form 4.

Corporate Governance Expert

TL;DR: The report documents standard Section 16 disclosures: a director purchase and pre-existing director-held warrants with defined exercise terms.

This Form 4 shows compliance with Section 16 reporting: the reporting person is identified as a director and the transaction date and signature are provided. The explanation clarifies warrant issuance mechanics: initial exercise six months after grant and a five-year exercise window measured from initial exercise. The filing contains no amendments or additional governance actions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

SCHECHTER JONATHAN

(Last) (First) (Middle)

110 16TH STREET

SUITE 1400 #1024

(Street)

DENVER CO 80202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Oblong, Inc. [ OBLG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/16/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
COMMON STOCK	09/16/2025		P		10,000	A	$2.7321	10,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Warrant(1)	$3.4144							10/01/2023	10/01/2028	Common Stock	61,351		61.351	D

Explanation of Responses:

1. Represents the issuance of warrants to purchase common stock of the issuer. The initial exercise date of the warrants was six months from the grant date, and the warrants expire on the fifth anniversary of the initial exercise date.

	/s/ Johnathan Schechter	09/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Oblong insider Jonathan Schechter report on Form 4 (OBLG)?

The filing reports that on 09/16/2025 Jonathan Schechter acquired 10,000 common shares at $2.7321 per share and beneficially owns 10,000 shares.

How many warrants does the Form 4 disclose and what are their terms for OBLG?

The Form 4 discloses warrants with an exercise price of $3.4144, dated 10/01/2023, expiring 10/01/2028, underlying 61,351 shares.

Does the Form 4 indicate the reporting person's role at Oblong (OBLG)?

Yes. The filing identifies the reporting person as a Director of Oblong, Inc.

Was the Form 4 filed jointly or by a single reporting person for OBLG?

The filing indicates it was filed by one reporting person.

Is there an explanation of the warrant issuance in the Form 4?

Yes. The filing explains warrants were issued with an initial exercise date six months after grant and expire five years after the initial exercise date.